# Corporate quarterly earnings reports

> Developing situation record from CLSTR: https://clstr.news/situations/20261110-corporate-quarterly-earnings-reports
> Updated: 2026-11-10T22:15:18.000Z. Sources: 6. Developments: 2.

The period saw financial reporting from major corporations. Elanco Animal Health reported third-quarter revenue of US$ 1.3 billion, an 11 percent increase from the previous year, moving from a net loss in 2025 to a net profit of US$ 18.0 million. Growth was driven by the Pet Health and livestock segments. 

Alcon reported third-quarter revenue of $2.72 billion, a 5 percent increase in constant currency. The company saw growth in its Vision Care and Surgical segments, though it noted competitive pressure regarding intraocular lenses in the United States.

## Timeline

### 2026-11-10: Alcon reports third quarter revenue growth to $2.7 billion

Alcon reported a 5 percent revenue increase to $2.72 billion in Q3, driven by Vision Care despite competitive pressure on intraocular lenses in the US.

4 sources. https://clstr.news/cluster/alcon-reports-third-quarter-revenue-growth-to-27-billion

### 2026-11-09: Elanco reports US$ 1.3 billion in third quarter revenue

Elanco Animal Health reported US$ 1.3 billion in Q3 2026 revenue, an 11% increase, and raised its full-year financial guidance.

2 sources. https://clstr.news/cluster/elanco-reports-us-13-billion-in-third-quarter-revenue

---
Cite as: Corporate quarterly earnings reports. CLSTR, https://clstr.news/situations/20261110-corporate-quarterly-earnings-reports
